2023
DOI: 10.1016/j.yebeh.2023.109159
|View full text |Cite
|
Sign up to set email alerts
|

Real-world, long-term evaluation of the tolerability and therapy retention of Epidiolex® (cannabidiol) in patients with refractory epilepsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…drug-resistant epilepsy in Dravet syndrome, early childhood epileptic encephalopathy and drug-resistant epilepsy with focal seizures after the ineffectiveness of the third or subsequent line of treatment due to its anticonvulsant effect. (33,35)…”
Section: Potential Uses Of Medical Marijuanamentioning
confidence: 99%
“…drug-resistant epilepsy in Dravet syndrome, early childhood epileptic encephalopathy and drug-resistant epilepsy with focal seizures after the ineffectiveness of the third or subsequent line of treatment due to its anticonvulsant effect. (33,35)…”
Section: Potential Uses Of Medical Marijuanamentioning
confidence: 99%